Event Type
Disclosure
Mandatory
Variant
8-K
(including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On January 5,
Other Events. On January 8, 2026 the Company issued a press release announcing updates to its Board and leadership team. A copy of this press release is filed a
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release issued by CorMedix Inc., dated January 8, 2026. 99.2 Press Release i